Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sunshine Biopharma (SBFM)

Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 803
  • Shares Outstanding, K 995
  • Annual Sales, $ 24,090 K
  • Annual Income, $ -4,510 K
  • 60-Month Beta 1.17
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book 0.01
Trade SBFM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +42.00%
on 04/25/24
13.2500 -91.96%
on 04/01/24
-4.6450 (-81.35%)
since 03/26/24
3-Month
0.7500 +42.00%
on 04/25/24
28.5600 -96.27%
on 01/31/24
-24.3350 (-95.81%)
since 01/26/24
52-Week
0.7500 +42.00%
on 04/25/24
140.0000 -99.24%
on 05/11/23
-62.0550 (-98.31%)
since 04/26/23

Most Recent Stories

More News
Coronavirus Vaccine Market To Surpass $95 Billion By 2028

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 1.1000 (+36.24%)
MRNA : 107.63 (+1.37%)
NVAX : 4.11 (+4.05%)
VIR : 8.18 (+7.21%)
INO : 10.59 (+4.64%)
Coronavirus Vaccine Market To Surpass $95 Billion By 2028

/PRNewswire/ -- The Coronavirus Global Market has been growing in the past few years and is anticipated to continue to grow in the next several years. In fact,...

SBFM : 1.1000 (+36.24%)
MRNA : 107.63 (+1.37%)
NVAX : 4.11 (+4.05%)
VIR : 8.18 (+7.21%)
INO : 10.59 (+4.64%)
SUNSHINE BIOPHARMA SIGNS EXCLUSIVE WORLDWIDE LICENSE WITH UNIVERSITY OF ARIZONA FOR PLpro-BASED COVID-19 TREATMENT

Montreal – February 28, 2023 – Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and...

SBFM : 1.1000 (+36.24%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID

/PRNewswire/ -- Research and development is still focused on trying to help understand the acute infection 9itself and the effects of long COVID as well. As...

OCEL : 2.7500 (unch)
RGNX : 16.39 (+2.05%)
SBFM : 1.1000 (+36.24%)
ABBV : 158.40 (-5.31%)
RVNC : 3.48 (+5.78%)
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID

Palm Beach, FL – November 17, 2022 – FinancialNewsMedia.com News Commentary – Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the...

SBFM : 1.1000 (+36.24%)
ABBV : 158.40 (-5.31%)
OCEL : 2.7500 (unch)
RGNX : 16.39 (+2.05%)
RVNC : 3.48 (+5.78%)
Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona

MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical...

SBFM : 1.1000 (+36.24%)
SBFMW : 0.0568 (+13.37%)
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market

MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a...

SBFM : 1.1000 (+36.24%)
SBFMW : 0.0568 (+13.37%)
Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM)

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

SBFM : 1.1000 (+36.24%)
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a...

SBFM : 1.1000 (+36.24%)
SBFMW : 0.0568 (+13.37%)
Advanced Immunological and Clinical Trials for Treating Ovarian Cancer Accelerating

Palm Beach, FL – April 25, 2022 – FinancialNewsMedia.com News Commentary – The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer...

BIOV.CN : 0.0750 (-11.76%)
BVAXF : 0.0625 (unch)
CTIC : 9.09 (unch)
IMGN : 31.23 (unch)
CLVS : 0.0812 (-5.58%)
SBFM : 1.1000 (+36.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

See More

Key Turning Points

3rd Resistance Point 1.0216
2nd Resistance Point 0.9558
1st Resistance Point 0.8816
Last Price 1.1000
1st Support Level 0.7416
2nd Support Level 0.6758
3rd Support Level 0.6016

See More

52-Week High 140.0000
Fibonacci 61.8% 86.8065
Fibonacci 50% 70.3750
Fibonacci 38.2% 53.9435
Last Price 1.1000
52-Week Low 0.7500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar